Healthcare stocks spearheaded Wall Street’s advance on Tuesday, fueled by encouraging clinical trial data and upbeat projections for the healthcare industry. The sector’s robust performance provided a significant boost to the broader market indices. Several leading healthcare companies experienced substantial gains, reflecting investor optimism regarding future growth prospects and innovation within the industry. This positive trend underscores the resilience and importance of the healthcare sector in the current economic landscape.